FIELD: medicine.
SUBSTANCE: group of inventions relates to a method for preventing and/or treating herpes. Patient is administered an effective amount of glutaryl histamine or a pharmaceutically acceptable salt thereof. Group of inventions also relates to a pharmaceutical composition for treating herpes, containing an effective amount of glutaryl histamine or a pharmaceutically acceptable salt thereof.
EFFECT: using this group of inventions makes it possible to restore or increase density of interferon receptors for overcoming resistance to therapy with interferons.
7 cl, 3 dwg, 1 tbl, 5 ex
Authors
Dates
2016-08-27—Published
2013-09-03—Filed